Is computed tomographic colonography being held to a higher standard?

Area of Science:

• Medical Imaging
• Gastroenterology
• Oncology

Background:

• Colorectal cancer screening guidelines differ on the acceptability of computed tomographic colonography (CTC).
• The Centers for Medicare & Medicaid Services (CMS) recently excluded CTC from screening coverage.
• Concerns cited include radiation exposure, detection rates for small polyps, and extracolonic findings.

Purpose of the Study:

• To analyze the rationale behind the exclusion of CTC from recommended screening protocols.
• To compare the standards applied to CTC with those for other covered colorectal cancer screening methods.

Main Methods:

• Review of current guidelines and CMS coverage decisions for colorectal cancer screening.
• Analysis of cited concerns regarding CTC performance and safety.
• Comparative assessment of evidence requirements for CTC versus other screening modalities.

Main Results:

• Key concerns against CTC include radiation, false negatives for small polyps, extracolonic findings, performance variability, and lack of targeted studies.
• A higher adenoma detection rate in the Medicare-eligible population was noted.
• The evidence suggests CTC might be evaluated by a stricter standard than other screening tests.

Conclusions:

• The exclusion of CTC screening by CMS and differing guideline recommendations warrant further investigation.
• Concerns raised about CTC are comparable to those for other established screening tests.
• There is a potential for CTC to be held to a new and higher standard compared to existing colorectal cancer screening options.